Abstract
Chimeric antigen receptor T cells remained detectable in two early recipients who sustained decade-long remissions. The cells' characteristics had shifted over the years, however, with CD4-expressing cells that retained anticancer activity becoming dominant.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
